JACKELINE TOMAS: Open Payments
NPI 1184143505 · HASBROUCK HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 14 payments from 5 companies in 2025. Trend: 2023 $338 · 2024 $62 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $120 |
| Novo Nordisk Inc | 6 | $95 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 3 | $47 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, ELIQUIS, MOUNJARO, Rybelsus, Wegovy, UBRELVY, Ozempic, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
